OSCAR YEE: Open Payments
NPI 1568132090 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 52 payments from 14 companies in 2025. Trend: 2023 $673 · 2024 $366 · 2025 $1,083
Food & beverage: $1,013Education: $70
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 20 | $364 |
| Ardelyx, Inc. | 6 | $139 |
| AKEBIA THERAPEUTICS INC | 1 | $122 |
| OPKO Pharmaceuticals, LLC | 4 | $70 |
| SCPHARMACEUTICALS INC. | 4 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Travere Therapeutics, Inc. | 3 | $53 |
| Vifor Pharma, Inc. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Amgen Inc. | 1 | $34 |
Products named: TARPEYO, IBSRELA, Vafseo, JARDIANCE, RAYALDEE, FUROSCIX, Veltassa, FARXIGA.
Industry payments across TX — which companies pay providers there.
